AC Immune SA ACIU
$ 3.22
-1.53%
Annual report 2023
added 11-09-2024
Country |
Schweiz |
IPO year |
2016 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Prof. Dr. Andrea Pfeifer |
Employees in the company |
115 |
Shares |
- |
Market Cap[1] |
$ 229 M |
EBITDA (LTM) |
$ -49.6 M |
P/E (LTM) |
- |
P/S (LTM) |
27.99 |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.